Renalytix AI plc

Ticker RENX

Exchange LSE More
Industry --None-- More
Sector Healthcare More

1-10 Employees
Based in London, England

Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosis™ for kidney health. They’ve engineered a new solution that successfully enables early-stage, progression risk assessment, when it counts the most.

Visit website

REPORT RATINGS

4.8 / 5.0 (72)

Renalytix AI plc reports have an aggregate usefulness score of 4.8 based on 72 reviews.

Renalytix AI plc